Found: 7
Select item for more details and to access through your institution.
Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 11, p. 1, doi. 10.1038/s41419-019-2098-8
- By:
- Publication type:
- Article
Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41419-017-0029-0
- By:
- Publication type:
- Article
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas.
- Published in:
- Cell Death & Disease, 2016, v. 7, n. 10, p. e2406, doi. 10.1038/cddis.2016.232
- By:
- Publication type:
- Article
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells.
- Published in:
- Nature, 2001, v. 409, n. 6818, p. 355, doi. 10.1038/35053094
- By:
- Publication type:
- Article
Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 6, p. e2113205, doi. 10.1001/jamanetworkopen.2021.13205
- By:
- Publication type:
- Article
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 11, p. e2241538, doi. 10.1001/jamanetworkopen.2022.41538
- By:
- Publication type:
- Article